期刊文献+

羟基喜树碱自乳化传递系统的处方筛选和体外评价 被引量:4

Design and in vitro evaluation of self-emulsifying drug delivery system for HCPT
下载PDF
导出
摘要 筛选和制备羟基喜树碱自乳化传递系统的处方并进行体外评价.以平衡质量浓度方法考察了羟基喜树碱在不同的油相、乳化剂和助乳化剂中的质量浓度,通过三元相图辅助筛选处方的组成,采用星点设计-效应面法优化处方中各组分的比例,筛选和制备了羟基喜树碱自乳化传递系统.考察自乳化制剂的粒径、累积溶出度、自乳化速率、微乳形态及其初步稳定性等.筛选出由m(氢化玉米油)∶m(辛酸癸酸甘油酯)=1∶1为混合油相,m(聚氧乙烯蓖麻油)∶m(辛酸葵酸聚乙二醇甘油酯)=2∶1为混合乳化剂,二乙烯基乙二醇单乙醚为助乳化剂和羟基喜树碱组成的自乳化传递系统.所得的优化处方可自发形成均匀球状液滴,微乳平均粒径在30nm左右且分布窄,自乳化速率在5min以内,溶出度在60min内达到90%以上,而且制剂稳定性良好.通过处方研究确定了最优处方,研制了羟基喜树碱自乳化传递系统. The self-emulsifying drug delivery system (SEDDS) of HCPT was developed and the properties in vitro were assessed. The solubility of HCPT in several oils and emulsifiers and assistant emulsifiers was determined by balance solubility method. Ternary phase diagram was used to select formulation composition and a central composite design-response surface methodology was used to optimize formulation. The droplet size, accumulative dissolving, self- emulsifying rate, microemulsion form and preliminary stability of the preparation were determined to prove that the dosage form is a useful deliverlity system for HCPT. In the optmiaed HCPT-SEDDS, the mixture of m (Maisine 35-1) : m (GTCC) = 1 " 1, m (CremophorEL):m (Labrasol)= 2 : 1, Transcutol P used as oil, emulsifier and assistant emulsifier respectively. This HCPT-SEDDS could be self-emulsified to form uniform globular droplets, the average particle size of microemulsion was about 30 nm and had narrow distribution, the selfemulsifying rate was about 5 min, the accumulative dissolving could reach more than 90% in 1 h, and its stability is fine. The optimized SEDDS for HCPT was obtained.
出处 《浙江工业大学学报》 CAS 2012年第3期237-243,共7页 Journal of Zhejiang University of Technology
基金 浙江省中医科学研究基金资助项目(2006C153)
关键词 羟基喜树碱 自乳化传递系统 星点设计-效应面法 体外评价 hydroxycamptothecin (HCPT) self-emulsifying drug delivery system (SEDDS) central composite design-response surface methodology evaluation in vitro
  • 相关文献

参考文献7

  • 1GURSOY R N, BENITA S. Self-emulsifying drug delivery systems(SEDDS) for improved oral delivery of lipophilic drugs [J]. Biomed Pharmacother, 2004,58 (3) : 173-182.
  • 2SHAN N H, CARVAJAL M T, MALICK A W, et al. Self-e- mulsifying drug delivery systems (SEDDS) with polyglyco- lyzed glycerides for improving in vitro dissolution and oral ab- sorption of lipophilic drugs[J]. Int J Pharm, 1994,106 (1) : 15- 23.
  • 3ZHANG Rui-wen, LI Yu-feng, CAI Qiu-yin, et al. Preelinieal pharmacology of the natural product anticancer agent 10- hydroxycamptothecin, an inhibit or of topoisomerase I[J]. Cancer Chemother Pharmaeol, 1998,41 (4) : 257-267.
  • 4HATEFI A, AMSDEN B. Camptothecin delivery methods [J]. Pharm Res, 2002,19 (10) : 1389-1399.
  • 5潘国梁,贾晓斌,魏惠华,王勇.药用微乳伪三元相图的几种制备方法比较研究[J].中国药房,2006,17(1):21-23. 被引量:61
  • 6吴伟,崔光华.星点设计-效应面优化法及其在药学中的应用[J].国外医学(药学分册),2000,27(5):292-298. 被引量:426
  • 7SINTOV A C, SHAPIRO L. New microemulsion vehicle facil- itates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo[J]. Control Release,2004,95(2) :173- 183.

二级参考文献5

  • 1Alany RG, Rades TS.Agatonovic - kustrin S, et al. Effect of alcohols and diols on the phase behaviour of quaternary systems[J]. Int J Pharm, 2000,196(2):141.
  • 2Gao P, Rush BD, Pfund WP, et al .Development of a supersaturable SEDDS(S-SEDDS) formulation of paclitaxel with improved oral bioavailability[J] .J Pharm Sci, 2003,92 (12) : 2 386.
  • 3Sébastien Branchu,Robert T. Forbes,Peter York,H?kan Nyqvist. A Central Composite Design to Investigate the Thermal Stabilization of Lysozyme[J] 1999,Pharmaceutical Research(5):702~708
  • 4Emad Eldin Hassan,Roy C. Parish,James M. Gallo. Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, Oxantrazole[J] 1992,Pharmaceutical Research(3):390~397
  • 5陆彬,张正全.用三角相图法研究药用微乳的形成条件[J].药学学报,2001,36(1):58-62. 被引量:83

共引文献483

同被引文献92

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部